Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

First European AF procedures are performed with magnetic irrigated catheter

Stereotaxis : 06 November, 2007  (New Product)
Stereotaxis has recently successfully performed the first atrial fibrillation procedures with its partnered magnetic irrigated catheter.
The magnetic irrigated Catheter has CE Mark approval for the remote ablation of arrhythmias and is being released in phases to physicians in Europe.

'The first uses of our partnered irrigated Catheter in Europe are a double achievement,' said Bevil Hogg, CEO of Stereotaxis.

'First, the cases were remarkable for their efficiency and efficacy, and we are extremely pleased with the results. Secondly, combined with our Stereotaxis Magnetic Navigation System and new NaviLine software, the irrigated Catheter completes Stereotaxis' total solution for atrial fibrillation, a solution that we believe will significantly advance the treatment of complex arrhythmias and potentially become standard of care for a growing number of cases. Near term, we believe that widespread adoption of our partnered magnetic irrigated Catheter in Europe will bring even greater simplicity and safety to atrial fibrillation procedures performed there, and we look forward to these clinical benefits becoming available to patients and clinicians in the USA after appropriate regulatory approval.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo